Indiana University School of Medicine researchers are taking a closer look at a disease whose incidence is rising as obesity in children increases. Non-Alcoholic Steatohepatitis, more popularly known as Fatty Liver Disease, occurs in approximately 15% of obese children.
University of Florida researchers have used an experimental therapy in mice to shut down a gene that plays a crucial role in a leading cause of inherited blindness.
A clinical trial conducted by researchers at the Johns Hopkins Bloomberg School of Public concluded that daily zinc supplements reduced the risk of death among children aged 12 to 48 months by 18 percent. However, the researchers did not find any significant reduction in mortality among children 1 to 11 months of age.
A new study by researchers at the University of Virginia Health System may change the way physicians assess a patient?s risk of having a stroke.
According to a new study from the University of Rochester, playing action video games sharpens vision. In tests of visual acuity that assess the ability to see objects accurately in a cluttered space, game players scored higher than their non-playing peers.
Patients in Liverpool are to trial a new therapy for pancreatic cancer — a disease which sees most sufferers die within a year of diagnosis.
Colorectal cancer patients who undergo colonoscopic surveillance during follow-up after surgery experience improved survival, according to a study to be published in the April issue of Clinical Gastroenterology and Hepatology but currently available online.
Doctors at the University of Maryland Medical Center had a mystery on their hands. A 51-year-old physician colleague who looked the picture of health?no cardiovascular risks, a marathon runner who had exercised vigorously each day for 30 years?had just flunked a calcium screening scan of his heart.
Suicide rates in Queensland have been relatively stable over recent years according to the latest available data but more than 500 deaths each year is no comfort to the many families and friends left behind.
A small clinical trial of a medication to treat kleptomania has failed to find any conclusive benefit for patients with the impulsive stealing disorder, according to researchers at the Stanford University School of Medicine